Profile
| Metric | Value |
|---|---|
| Full Name | Eagle Pharmaceuticals, Inc. |
| Ticker | NASDAQ: EGRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | eagleus.com |
| Employees | 134 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.25 | ||
| Price, 1D Change | 0.00% | |
| $3M | ||
| - | ||
| 0.27 | ||
| -0.13 | ||
| $317M | ||
| Revenue, 1Y Change | +84.56% | |
| $2.73 | ||
| EPS, 1Y Change | +512.71% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $2.73 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $316.61M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.25 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| $224.81M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -78.99% | ||
| -99.19% | ||
| -79.10% | ||
| -99.20% | ||
| +84.56% | ||
| +61.62% | ||
| +512.71% | ||
| +169.49% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.25 | ||
| $1.93 | ||
| SMA 200 vs Price | +671.60% | |
| $0.45 | ||
| SMA 50 vs Price | +79.68% | |
| -0.13 | ||
| $0.11 | ||
| 39.77 | ||
| 274.90% | ||
| 307.99% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $316.61M | ||
| $2.73 | ||
| $221.03M | ||
| 69.81% | ||
| $93.56M | ||
| -0.64% | ||
| $35.64M | ||
| 11.26% | ||
| $106.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.28 | ||
| 1.70 | ||
| 1.22 | ||
| - | ||
| 5 | ||
| 2.16 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 0.27 | ||
| 0.01 | ||
| 0.01 | ||
| 0.94 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $233.56M | ||
| $55.32M | ||
| $406.16M | ||
| $188.75M | ||
| $172.60M | ||
| $111.09M | ||
| $65.51M | ||
| $7.78M | ||
| $18.99M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $280.97M | ||
| $127.47M | ||
| $95.58M | ||
| $106.63M | ||
| $13.27M | ||
| $0.00 | ||
| $25.79M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $50.70M | ||
| -$86.83M | ||
| -$6.21M | ||
| $178.00K | ||
| $50.52M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| Cantor Fitzgerald | ||
| Mizuho | → | |
| PiperJaffray | → | |
| Piper Sandler | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | ||
| Mizuho | → | |
| Mizuho | → | |
| Mizuho | → |
Analyst sentiment
Institutional ownership
Screeners with EGRX
FAQ
What is the ticker symbol for Eagle Pharmaceuticals, Inc.?
The ticker symbol for Eagle Pharmaceuticals, Inc. is NASDAQ:EGRX
Does Eagle Pharmaceuticals, Inc. pay dividends?
No, Eagle Pharmaceuticals, Inc. does not pay dividends
What sector is Eagle Pharmaceuticals, Inc. in?
Eagle Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Eagle Pharmaceuticals, Inc. in?
Eagle Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Eagle Pharmaceuticals, Inc. based in?
Eagle Pharmaceuticals, Inc. is headquartered in United States
When did Eagle Pharmaceuticals, Inc. go public?
Eagle Pharmaceuticals, Inc. initial public offering (IPO) was on February 12, 2014
Is Eagle Pharmaceuticals, Inc. in the S&P 500?
No, Eagle Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Eagle Pharmaceuticals, Inc. in the NASDAQ 100?
No, Eagle Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Eagle Pharmaceuticals, Inc. in the Dow Jones?
No, Eagle Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Eagle Pharmaceuticals, Inc. last earnings report?
Eagle Pharmaceuticals, Inc.'s most recent earnings report was on March 15, 2024
When does Eagle Pharmaceuticals, Inc. report earnings?
The date for Eagle Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- EGRX Official Website www.eagleus.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/827871/000082787123000024/0000827871-23-000024-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/827871/000082787123000009/0000827871-23-000009-index.htm
- EGRX Profile on Yahoo Finance finance.yahoo.com/quote/EGRX
- EGRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/egrx